EQS-Adhoc: Acer Therapeutics and Relief Therapeutics Announc

EQS-Adhoc: Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences

EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Conference Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences 27-Jan-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer...

Related Keywords

Nevada , United States , University Of Washington , Washington , Florida , Geneva , Genè , Switzerland , California , Wisconsin , University Of Wisconsin , Orlando , Seattle , Swiss , Phenylbutyrate Acer , Jim Denike , Michael Miller , Hans Vitzthum , Las Vegas , Robert Steiner , Chris Schelling , Robertd Steiner , Raghuram Ram Selvaraju , Jack Weinstein , Advita Lifescience Gmb , Stephen Cederbaum , University Of California , Genetic Metabolic Dieticians International , Stock Exchange , Rx Communications Group , Holding Ag Key , Nasdaq , News Service , Acer Therapeutics Inc , Society For Inherited Metabolic Disorders , Drug Administration , Pharma Research , Swiss Exchange , Wisconsin Newborn Screening Program Medical Consultant , Exchange Commission , Professor Clinical University Of Wisconsin , European Medicines Agency , Neurorx Inc , Relief Therapeutics Announce Presentation , Inherited Metabolic Disorders , Annual Meeting , Drug Application , Prescription Drug User Fee Act , Chief Executive Officer , Taste Masked Sodium Phenylbutyrate , Urea Cycle Disorders Under Fasting , Fed Conditions , Taste Masked Coating , Sodium Phenylbutyrate , Urea Cycle , Unmet Needs , Urea Cycle Disorders , Chief Medical Officer , Potential Alternative , Glycerol Phenylbutyrate , Protein Needs , What We Know , What We Need , Move Towards Personalized Care , Deborah Geary Hook , Phd Candidate , Molecular Genetics , Maple Syrup Urine Disease , Vasomotor Symptoms , License Agreement , Vasoactive Intestinal Peptide , Acer Therapeutics , Maple Syrup Urine , Advita Lifescience Gmbh , Private Securities Litigation Reform Act , Quarterly Reports , Annual Report , Financial Officer , Therapeutics , Nnounce , Presentation , Four , Cer 001 , Posters , Pcoming , Imd , Tmdi , Conferences , Et Cest , Release , Art , Dr , The ,

© 2025 Vimarsana